WELLINGTON MANAGEMENT GROUP LLP
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 902219
Boston, MA
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,042,524
+$179,142 QoQ
Shares Held
25,659
-6.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 223 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. EWTX ranks #157 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in EWTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,524 | 25,659 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $863,382 | 27,409 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,764,067 | 111,387 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,857,692 | 114,531 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,475,791 | 112,570 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,492,666 | 113,303 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,417,242 | 202,893 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,480,016 | 205,321 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,894,183 | 493,847 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,625,750 | 472,903 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,729,511 | 340,906 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,953,391 | 340,906 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,642,021 | 340,906 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,273,843 | 340,906 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,047,699 | 340,906 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,354,515 | 340,906 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,713,611 | 340,906 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,306,788 | 340,906 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,418,087 | 681,812 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $11,318,079 | 681,812 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,818,071 | 741,588 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,128,390 | 742,412 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||